Intraoperative Methadone for Postoperative Pain in Patients Undergoing Tonsillectomy

Last updated: December 4, 2023
Sponsor: University of Aarhus
Overall Status: Active - Recruiting

Phase

4

Condition

Post-surgical Pain

Chronic Pain

Pain

Treatment

Methadone

Fentanyl

Clinical Study ID

NCT05445856
2022-002496-11
  • Ages 18-100
  • All Genders
  • Accepts Healthy Volunteers

Study Summary

A randomized controlled trial evaluating the efficacy and safety of single-shot intraoperative methadone for postoperative pain in patients undergoing tonsillectomy. Fentanyl is used as an active comparator

Eligibility Criteria

Inclusion

Inclusion Criteria:

  • All patients (≥18 years) scheduled for elective tonsillectomy

Exclusion

Exclusion Criteria:

  • American Society of Anaesthesiologists (ASA) physical status IV or V
  • Allergy to study drugs
  • Daily use of opioids 7 days prior to surgery
  • Inability to provide informed consent
  • Severe respiratory insufficiency
  • Heart failure
  • Acute alcohol intoxication/delirium tremens
  • Increased intracranial pressure
  • Acute liver disease
  • Liver insufficiency
  • Kidney insufficiency
  • Treatment with rifampicin
  • Treatment with any drug prolonging the QT-interval
  • Pregnancy (every female not using contraceptives will be screened with urine humanchoriogonadotropin)
  • Breastfeeding

Study Design

Total Participants: 130
Treatment Group(s): 2
Primary Treatment: Methadone
Phase: 4
Study Start date:
November 28, 2022
Estimated Completion Date:
August 31, 2024

Study Description

This study is an investigator-initiated, prospective, randomised controlled trial with two arms: an intervention arm (methadone) and a control arm (fentanyl). Patients scheduled for tonsillectomy at Randers Regional Hospital, Denmark, will be approached for study participation.

Patients are randomised in a 1:1 ratio in blocks of varying sizes (between 4 and 8) to receive either intraoperative methadone or fentanyl. The randomisation assignment will be handled by the hospital pharmacy using a web-based central randomisation procedure (www.sealedenvelope.com).

The study drug will be prepared by the hospital pharmacy at Aarhus University Hospital and delivered as kits with identical appearance, marked with the randomization number (1-130). On the day of surgery, a kit will be opened and a 10 ml syringe with study drug (methadone 2 mg/ml or fentanyl 30 microgram/ml or ) will prepared by a health care professional (nurse or medical doctor not involved in the study or the treatment of patients). Once prepared, the blinded study drug will be given to and handled by one of the research team members and administered after induction of anesthesia and prior to surgery

The dose of the study drug will be administered as intravenous bolus dose in equipotent doses (0.2 mg/kg / 3 μg/kg) corresponding to 1 ml for every 10 kg of ideal body weight (women: height (cm) - 105. Men: height (cm) - 100)) after induction of anaesthesia and before the start of surgery.

Postoperative data will be obtained by reviewing hospital records, by interview and electronic questionnaires sent by email.

Connect with a study center

  • Department of Anaesthesiology and Intensive Care

    Randers,
    Denmark

    Active - Recruiting

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.